« previous next »
Pages: [1]

Author Topic: NEPAD and Ocrevus  (Read 117 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9664
  • MS diagnosed 1980
  • Location: Pacific Northwest
NEPAD and Ocrevus
« on: February 19, 2018, 07:47:49 am »
This article is mainly pharma company promotion for Ocrevus but includes a discussion of a new standard being used to assess MS disease progression, NEPAD (no evidence of progression or active disease). From Multiple Sclerosis News Today, February 19, 2018:


https://multiplesclerosisnewstoday.com/2018/02/19/ocrevus-data-actrims-2018-reinforces-benefit-rrms-ppms-genetech-garren-interview/
Report to moderator   Logged
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.
Pages: [1]
« previous next »
 

Related Topics

  Subject / Started by Replies Last post
1 Replies
149 Views 		Last post February 23, 2017, 03:37:23 pm
by agate
1 Replies
200 Views 		Last post June 14, 2017, 10:35:24 am
by agate
0 Replies
98 Views 		Last post May 03, 2017, 02:18:40 pm
by agate
0 Replies
88 Views 		Last post July 22, 2017, 04:28:55 pm
by agate
0 Replies
144 Views 		Last post April 06, 2018, 06:37:14 am
by agate